Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-053010

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 13, 2017
Accepted (ET)
Sep 15, 2017 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Sep 13, 2017S1,000$65.47D86,394D
Common stockF2,F3Sep 13, 2017S1,000$65.47D86,434ISee footnote
Common stockF4Sep 14, 2017S1,000$65.71D85,394D
Common stockF4,F3Sep 14, 2017S1,000$65.71D85,434ISee footnote
Common stockF5holding———20,803ISee footnote
Common stockF6holding———20,803ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses